Cannabidiol, or CBD, does not produce the high commonly associated with marijuana.
That was after an announcement earlier in August from cannabis company HEXO that it was teaming up with Molson Coors Canada to develop cannabis-infused drinks.
The companies declined to comment on the report but acknowledged their interest in that segment of the cannabis market.
"We are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world", Coca-Cola spokesman Kent Landers said in an emailed statement to Bloomberg News. The new beverages will be pegged to drinkers who suffer with inflammation, pain or cramping.
Linton's comments come after Aurora CEO Terry Booth told BNN Bloomberg Monday that the pot producer had held discussions with at least three beverage companies in the past three months. "There are different viewpoints on a product category, and you don't want to offend too much", Dibadj said.
"The space is evolving quickly", Coca-Cola said.
These reports prompted several inquiries from readers about the veracity of claims that Coca-Cola was already in negotiations over a beverage that would contain CBD (cannabidiol).
All the interest from big name alcohol and beverage companies can only benefit the cannabis space, says Booth, Aurora's CEO. "No decisions have been made at this time", read the statement.
Canada is the first major economy to legalize recreational marijuana, and shares in cannabis producers have rallied in anticipation.
The marijuana company says it does engage in exploratory talks with industry participants from time to time, but there is no agreement or arrangement to announce.